NEW YORK (Reuters Health) - Testing for genetic defects early in pregnancy through chorionic villus sampling, or CVS, does not appear to raise the risk of fetal loss. CVS involves using a needle to ...

Chorionic villus sampling is a prenatal diagnostic test performed for prenatal genetic testing involving a biopsy of placental tissue between 10 to 13 weeks gestation. The tissue harvested is the ...

The risk of miscarriage after undergoing chorionic villus sampling, or CVS, to detect birth defects is lower than previously thought and essentially carries the same risk as the more commonly used ...

Further developments in paternity testing have arisen as a result of the rapidly evolving field of genetic testing technologies. A previous method of determining paternity during pregnancy was to do ...

When Charles Cantor and Dennis Lo flew to Pattaya, Thailand in late 2002 to attend a conference, neither man knew they would end up collaborating on a blood test that could one day reduce reliance on ...

Prenatal genetic testing determines if an offspring is at risk of genetic or hereditary conditions. This can inform the parents of decisions such as keeping the child or not or adjusting to help them ...